Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer

Dr. Haumann brings decades of respiratory drug expertise to support next phase of company growth CEO appointment follows recent clinical and corporate milestones including Phase 2b CARDINAL trial initiation and Series B financing ATLANTA, July 21, 2026 /PRNewswire/ -- Altesa BioSciences,...